![]() Sylentis Sylentis is a biotechnology company focused on the development of ophthalmic drugs and therapies based on RNAi (gene silencing) technology. | ![]() AnGes AnGes is a biopharmaceutical company specializing in R&D and practical application of genetic medicine. | ||
Founding Date | Founding Date 2009 | Founding Date 2006 | Founding Date 1999 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations Westminster, US HQ Westminster, US | Locations Tres Cantos, ES HQ Madrid, ES Mountain View, US | Locations Ibaraki, JP HQ Fujisawa, JP Ibaraki, JP Kawasaki, JP Minato City, JP Bethesda, US |
Employees | Employees 940% decrease | Employees 51 | Employees 5562% decrease |
Valuation ($) | Valuation ($) 34.8 m | Valuation ($) N/A | Valuation ($) 78.3 m |
Financial | |||
Net income | Net income ($105.4m) (FY, 2025) | Net income N/A | Net income (¥5.1b) (FY, 2025) |

Sylentis is a biotechnology company focused on the development of ophthalmic drugs and therapies based on RNAi (gene silencing) technology.
View company
AnGes is a biopharmaceutical company specializing in R&D and practical application of genetic medicine.
View company